Replies to post #201 on Versartis, Inc. (VSAR)

[Marilynt]

From Jay Shepard, president and CEO of Versartis:

We have done an initial analysis of the top-line data and are continuing to thoroughly review the results to gain greater insight into the trial outcome. We plan to provide a corporate update later this year.

http://247wallst.com/healthcare-business/2017/09/22/is-this-the-death-of-versartis/

When we hear the update, the sh will like move up to where it should be.